Fractionated radiotherapy for spinal tumors: A literature review regarding spinal glioma, ependymoma, and meningioma.

astrocytoma ependymoma glioma meningioma myxopapillary

Journal

Neuro-oncology advances
ISSN: 2632-2498
Titre abrégé: Neurooncol Adv
Pays: England
ID NLM: 101755003

Informations de publication

Date de publication:
Oct 2024
Historique:
medline: 21 10 2024
pubmed: 21 10 2024
entrez: 21 10 2024
Statut: epublish

Résumé

Radiation therapy plays a vital role in the management of primary spinal tumors in adults. However, due to the rarity of these tumor types, the literature on optimal treatment indications and radiation doses is limited. Many treatment recommendations are extrapolated from their cranial counterparts, where more data are available. Despite the absence of prospective data, numerous retrospective studies have provided valuable insights to guide treatment decisions until more comprehensive data become available. This review provides an overview of the most relevant literature, with a specific focus on spinal gliomas, ependymomas, and meningiomas, in the context of the role of radiation therapy.

Identifiants

pubmed: 39430392
doi: 10.1093/noajnl/vdad158
pii: vdad158
pmc: PMC11485843
doi:

Types de publication

Journal Article Review

Langues

eng

Pagination

iii101-iii109

Informations de copyright

© The Author(s) 2024. Published by Oxford University Press, the Society for Neuro-Oncology and the European Association of Neuro-Oncology.

Déclaration de conflit d'intérêts

M.N. received speaker honoraria from Brainlab that did not affect the current work. R.B., E.H., and C.B. state that they have no conflicts of interest.

Auteurs

Raphael Bodensohn (R)

Department of Radiation Oncology, University Hospital Tübingen, Tübingen, Germany.
Center for Neuro-Oncology, Comprehensive Cancer Center Tübingen-Stuttgart, University Hospital Tübingen, Tübingen, Germany.
Department of Radiation Oncology, LMU University Hospital, LMU Munich, Munich, Germany.

Erik Haehl (E)

Department of Radiation Oncology, LMU University Hospital, LMU Munich, Munich, Germany.

Claus Belka (C)

Department of Radiation Oncology, LMU University Hospital, LMU Munich, Munich, Germany.
Bavarian Cancer Research Center (BZKF), Munich, Germany.

Maximilian Niyazi (M)

Department of Radiation Oncology, University Hospital Tübingen, Tübingen, Germany.
Center for Neuro-Oncology, Comprehensive Cancer Center Tübingen-Stuttgart, University Hospital Tübingen, Tübingen, Germany.
Department of Radiation Oncology, LMU University Hospital, LMU Munich, Munich, Germany.
German Cancer Consortium (DKTK), partner site Tübingen, a partnership between DKFZ and University Hospital Tübingen, Tübingen, Germany.

Classifications MeSH